Health
Azithromycin use for treating COVID-19 may increase risk of cardiac events – News-Medical.net
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest.
Reviewed by Emily Henderson, B.Sc.Sep 16 2020
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest. Because of this, the U.S. Food and Drug Administration has revoked emergency use authorization for the drug in treating COVID-19.
Another drug, azithromycin — a commonly-prescribed antibiotic — also is being inves…
-
General16 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
General18 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
Noosa News19 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
Noosa News10 hours agoFatal traffic crash, Baringa – Sunshine Coast